Mezzion PharmaLtd Balance Sheet Health
Financial Health criteria checks 6/6
Mezzion PharmaLtd has a total shareholder equity of ₩55.1B and total debt of ₩0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are ₩77.5B and ₩22.4B respectively.
Key information
0%
Debt to equity ratio
₩0
Debt
| Interest coverage ratio | n/a |
| Cash | ₩41.12b |
| Equity | ₩55.07b |
| Total liabilities | ₩22.41b |
| Total assets | ₩77.48b |
Recent financial health updates
Here's Why We're Not Too Worried About Mezzion PharmaLtd's (KOSDAQ:140410) Cash Burn Situation
Nov 02
Recent updates
Here's Why We're Not Too Worried About Mezzion PharmaLtd's (KOSDAQ:140410) Cash Burn Situation
Nov 02Mezzion Pharma Co.,Ltd.'s (KOSDAQ:140410) Shareholders Might Be Looking For Exit
Sep 27Revenues Not Telling The Story For Mezzion Pharma Co.,Ltd. (KOSDAQ:140410)
Jun 11Optimistic Investors Push Mezzion Pharma Co.,Ltd. (KOSDAQ:140410) Shares Up 26% But Growth Is Lacking
Mar 04We Might See A Profit From Mezzion Pharma Co.,Ltd. (KOSDAQ:140410) Soon
Feb 05
Mezzion PharmaLtd (KOSDAQ:140410) Shareholders Have Enjoyed A Whopping 605% Share Price Gain
Dec 14Financial Position Analysis
Short Term Liabilities: A140410's short term assets (₩56.9B) exceed its short term liabilities (₩21.5B).
Long Term Liabilities: A140410's short term assets (₩56.9B) exceed its long term liabilities (₩915.5M).
Debt to Equity History and Analysis
Debt Level: A140410 is debt free.
Reducing Debt: A140410 has no debt compared to 5 years ago when its debt to equity ratio was 1.9%.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: A140410 has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: A140410 has sufficient cash runway for 2.2 years if free cash flow continues to grow at historical rates of 1.5% each year.